Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Aalborg
Clinical trial register · Denmark

Clinical Trials in Aalborg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2472 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:19 UTC
2472
Studies in scope
all four open statuses
1403
Recruiting now
open to new participants
448
Lead sponsors
across recruiting studies
Top sites
Aalborg 21 Copenhagen 20 Herlev 18 Aarhus N 16 Odense 14

Trials with a site in Aalborg

21 of 2472 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
AstraZeneca
Phase 3
7,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Roskilde
2026-08-21
Recruiting
AstraZeneca
Phase 2
435
Aalborg, Aarhus N, Hvidovre, Odense C, Roskilde
2025-11-06
Recruiting
AstraZeneca
Phase 2
987
Aalborg, Aarhus, Esbjerg, Hvidovre, Odense C, Roskilde
2025-06-27
Recruiting
AstraZeneca
Phase 3
990
Aalborg, Hvidovre, Næstved, Odense C, Vejle
2025-03-25
Recruiting
AstraZeneca
Phase 3
5,000
Aalborg, Aarhus, Copenhagen E, Herlev, Herning, Holbæk, Kolding
2025-03-03
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
AstraZeneca
Phase 1/2
408
Aalborg, Aarhus N, Copenhagen, Odense C
2025-01-30
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
AstraZeneca
Phase 2
270
Aalborg, Copenhagen, Vejle
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,018
Aalborg, Copenhagen, Odense C, Roskilde
2024-08-07
Active, closed
AstraZeneca
Phase 3
2,554
Aalborg, Aarhus, Copenhagen E, Esbjerg, Herlev, Herning, Holbæk
2024-03-29
Recruiting
AstraZeneca
Phase 3
5,250
Aalborg, Esbjerg, Hvidovre, København NV, Næstved, Vejle
2024-02-21
Active, closed
AstraZeneca
Phase 3
1,835
Aalborg, Aarhus, Herlev, Herning, Roskilde
2023-11-07
Recruiting
AstraZeneca
Phase 3
3,527
Aalborg, Aarhus N, Copenhagen, Copenhagen Ø, Herning, Hillerød, Hvidovre, Kolding
2022-12-13
Active, closed
AstraZeneca
Phase 3
893
Aalborg, Aarhus N, Hillerød, Odense
2021-05-10
Active, closed
AstraZeneca
Phase 3
957
Aalborg, København Ø, Odense
2020-11-17
Active, closed
AstraZeneca
Phase 3
185
Aalborg
2020-08-04
Active, closed
AstraZeneca
Phase 3
866
Aalborg, Copenhagen Ø, Odense, Vejle
2020-07-24
Active, closed
AstraZeneca
Phase 2
367
Aalborg, Herlev, København Ø, Næstved, Odense, Vejle
2019-01-09
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-denmark/city/aalborg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,472 studies in total at the last sync on 18 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Aalborg that also match the filters currently applied.

How many clinical trials are recruiting in Aalborg?

12 of the 21 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Aalborg), 21 studies
PhaseStudiesRecruitingShare
Phase 316876.2%
Phase 24319%
Phase 1/2114.8%

Most active sponsors

Lead sponsors with the most studies (Aalborg)
Lead sponsorStudiesRecruiting
AstraZeneca2112
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.